‘The sky didn’t fall in.’

Takeaway doses for opioid pharmacotherapy increased due to COVID-19 and gave patients more flexibility, but a leading pharmacist says there is a lack of financial support The COVID-19 pandemic brought some changes relating to pharmacotherapy treatment that have been welcomed by clinicians. Dr Suzie Hudson, Clinical Director of the Network of Alcohol and other Drugs

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Up to eight years for Canberra crime spree
Next The week in review